CN

Drug Conjugates for Global Patients

About MediLink

Drug Conjugates for Global Patients

About MediLink

Business

Focus on the ADC field, promote technology iteration and product development, and establish technology and product advantages

About MediLink

Medilink Therapeutics focuses on developing internationally competitive drug conjugates, as well as the latest generation of technologies and products with independent intellectual property rights and better therapeutic windows, to serve the unmet clinical needs. It strives to continuously upgrade technologies, establish diverse technology platforms for drug conjugates, and expand into new disease areas to serve global patients.

Learn more

Partner

With the continuous development of the company, we have won the favor of many partners